349 related articles for article (PubMed ID: 15695382)
41. Functional evaluation of variants of unknown significance in the BRCA2 gene identified in genetic testing.
Heczkova M; Machackova E; Macinga P; Gallmeier E; Cahova M; Spicak J; Jirsa M; Foretova L; Hucl T
Cancer Biol Ther; 2019; 20(5):633-641. PubMed ID: 30638113
[TBL] [Abstract][Full Text] [Related]
42. Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2.
Daniels MJ; Wang Y; Lee M; Venkitaraman AR
Science; 2004 Oct; 306(5697):876-9. PubMed ID: 15375219
[TBL] [Abstract][Full Text] [Related]
43. BRCA2 and nucleophosmin coregulate centrosome amplification and form a complex with the Rho effector kinase ROCK2.
Wang HF; Takenaka K; Nakanishi A; Miki Y
Cancer Res; 2011 Jan; 71(1):68-77. PubMed ID: 21084279
[TBL] [Abstract][Full Text] [Related]
44. Genome annotation by shotgun inactivation of a native gene in hemizygous cells: application to BRCA2 with implication of hypomorphic variants.
Ghosh S; Bhunia AK; Paun BC; Gilbert SF; Dhru U; Patel K; Kern SE
Hum Mutat; 2015 Feb; 36(2):260-9. PubMed ID: 25451944
[TBL] [Abstract][Full Text] [Related]
45. Functional assays for classification of BRCA2 variants of uncertain significance.
Farrugia DJ; Agarwal MK; Pankratz VS; Deffenbaugh AM; Pruss D; Frye C; Wadum L; Johnson K; Mentlick J; Tavtigian SV; Goldgar DE; Couch FJ
Cancer Res; 2008 May; 68(9):3523-31. PubMed ID: 18451181
[TBL] [Abstract][Full Text] [Related]
46. Functional impact of missense variants in BRCA1 predicted by supervised learning.
Karchin R; Monteiro AN; Tavtigian SV; Carvalho MA; Sali A
PLoS Comput Biol; 2007 Feb; 3(2):e26. PubMed ID: 17305420
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of conformational transitions of h-BRCA2 functional domain and unclassified variant Arg2502Cys using multimodal approach.
Khan MA; Siddiqui MQ; Kuligina E; Varma AK
Int J Biol Macromol; 2022 Jun; 209(Pt A):716-724. PubMed ID: 35413318
[TBL] [Abstract][Full Text] [Related]
48. Medicine. Possible new role for BRCA2.
Marx J
Science; 2004 Sep; 305(5691):1691. PubMed ID: 15375235
[No Abstract] [Full Text] [Related]
49. Genetic dissection of the BRCA2 promoter and transcriptional impact of DNA variants.
Fraile-Bethencourt E; Valenzuela-Palomo A; Díez-Gómez B; Infante M; Durán M; Marcos G; Lastra E; Gómez-Barrero S; Velasco EA
Breast Cancer Res Treat; 2018 Aug; 171(1):53-63. PubMed ID: 29766361
[TBL] [Abstract][Full Text] [Related]
50. A comprehensive analysis of BRCA2 gene: focus on mechanistic aspects of its functions, spectrum of deleterious mutations, and therapeutic strategies targeting BRCA2-deficient tumors.
Shailani A; Kaur RP; Munshi A
Med Oncol; 2018 Jan; 35(3):18. PubMed ID: 29387975
[TBL] [Abstract][Full Text] [Related]
51. Capillary electrophoresis analysis of conventional splicing assays: IARC analytical and clinical classification of 31 BRCA2 genetic variants.
de Garibay GR; Acedo A; García-Casado Z; Gutiérrez-Enríquez S; Tosar A; Romero A; Garre P; Llort G; Thomassen M; Díez O; Pérez-Segura P; Díaz-Rubio E; Velasco EA; Caldés T; de la Hoya M
Hum Mutat; 2014 Jan; 35(1):53-7. PubMed ID: 24123850
[TBL] [Abstract][Full Text] [Related]
52. BRCA2 in mitotic exit: a new role in regulating genomic stability.
Wang X; Dai W
Future Oncol; 2006 Feb; 2(1):43-6. PubMed ID: 16556071
[TBL] [Abstract][Full Text] [Related]
53. Biallelic FANCD1/BRCA2 mutations predisposing to glioblastoma multiforme with multiple oncogenic amplifications.
Dodgshun AJ; Sexton-Oates A; Saffery R; Sullivan MJ
Cancer Genet; 2016; 209(1-2):53-6. PubMed ID: 26740091
[TBL] [Abstract][Full Text] [Related]
54. A syngeneic variance library for functional annotation of human variation: application to BRCA2.
Hucl T; Rago C; Gallmeier E; Brody JR; Gorospe M; Kern SE
Cancer Res; 2008 Jul; 68(13):5023-30. PubMed ID: 18593900
[TBL] [Abstract][Full Text] [Related]
55. A new assay for functional screening of BRCA2 linker region mutations identifies variants that alter chemoresistance to cisplatin.
Warren CR; Catts ZA; Farach-Carson MC
Exp Cell Res; 2011 Sep; 317(15):2099-109. PubMed ID: 21741379
[TBL] [Abstract][Full Text] [Related]
56. Targeting Tankyrase 1 as a therapeutic strategy for BRCA-associated cancer.
McCabe N; Cerone MA; Ohishi T; Seimiya H; Lord CJ; Ashworth A
Oncogene; 2009 Mar; 28(11):1465-70. PubMed ID: 19182824
[TBL] [Abstract][Full Text] [Related]
57. Functional analysis of human BRCA2 variants using a mouse embryonic stem cell-based assay.
Kuznetsov SG; Chang S; Sharan SK
Methods Mol Biol; 2010; 653():259-80. PubMed ID: 20721749
[TBL] [Abstract][Full Text] [Related]
58. An efficient pipeline for the generation and functional analysis of human BRCA2 variants of uncertain significance.
Hendriks G; Morolli B; Calléja FM; Plomp A; Mesman RL; Meijers M; Sharan SK; Vreeswijk MP; Vrieling H
Hum Mutat; 2014 Nov; 35(11):1382-91. PubMed ID: 25146914
[TBL] [Abstract][Full Text] [Related]
59. Structural analysis of the chicken BRCA2 gene facilitates identification of functional domains and disease causing mutations.
Warren M; Smith A; Partridge N; Masabanda J; Griffin D; Ashworth A
Hum Mol Genet; 2002 Apr; 11(7):841-51. PubMed ID: 11929857
[TBL] [Abstract][Full Text] [Related]
60. Tumour suppressor mechanisms in the control of chromosome stability: insights from BRCA2.
Venkitaraman AR
Mol Cells; 2014 Feb; 37(2):95-9. PubMed ID: 24598993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
